Holdings in GSK
| Report Date |
Value (USD) |
Shares |
Change |
Type |
Discretion |
Filed |
| 2025-12-31 |
$3,308,699,814 |
67,469,409 |
+2.0%
|
Shares |
Defined |
2026-02-17 |
| 2025-09-30 |
$2,854,753,458 |
66,143,500 |
+8.4%
|
Shares |
Defined |
2025-11-13 |
| 2025-06-30 |
$2,342,536,089 |
61,003,544 |
+1.5%
|
Shares |
Defined |
2025-08-14 |
| 2025-03-31 |
$2,329,068,827 |
60,120,517 |
+13.8%
|
Shares |
Defined |
2025-05-12 |
| 2024-12-31 |
$1,786,474,940 |
52,823,032 |
+82.1%
|
Shares |
Defined |
2025-02-13 |
| 2024-09-30 |
$1,185,884,974 |
29,008,928 |
+19.3%
|
Shares |
Defined |
2024-11-13 |
| 2024-06-30 |
$936,148,212 |
24,315,538 |
-1.1%
|
Shares |
Defined |
2024-08-13 |
| 2024-03-31 |
$1,053,796,984 |
24,581,222 |
+26.9%
|
Shares |
Defined |
2024-05-13 |
| 2023-12-31 |
$717,708,812 |
19,366,131 |
+7.0%
|
Shares |
Defined |
2024-02-13 |
| 2023-09-30 |
$656,107,344 |
18,099,513 |
+7.7%
|
Shares |
Defined |
2023-11-13 |
| 2023-06-30 |
$599,049,662 |
16,808,352 |
+8.6%
|
Shares |
Defined |
2023-08-11 |
| 2023-03-31 |
$550,651,449 |
15,476,432 |
+3.4%
|
Shares |
Defined |
2023-08-11 |
| 2022-12-31 |
$525,711,300 |
14,960,481 |
+6.3%
|
Shares |
Defined |
2023-02-13 |
| 2022-09-30 |
$414,009,319 |
14,067,595 |
—
|
Shares |
Defined |
2022-11-10 |
